Granisetron

FDA Approved: * December 31, 2007
Pharm Company: * SICOR PHARMS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Granisetron Overview

Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and Radiotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors. Granisetron was developed by chemists working at the British dr...

Read more Granisetron Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Granisetron

Recent Granisetron Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Granisetron
  • Film, Extended Release: 3.1mg/24hr
  • Injection: (1mg/ml) 1mg/1ml, (1mg/ml) 4mg/4ml, 0.1mg/ml, 0.1mg/ml (0.1mg/ml), 10mg/0.4ml, 1mg, 1mg/ml, 1mg/ml (1mg/ml), 3mg/ml, 4mg/4ml (1mg /ml), 4mg/4ml (1mg/ml)
  • Injection, Extended Release: 10mg/0.4ml (10mg/0.4ml)
  • Solution: 2mg/10ml
  • System: 3.1mg
  • Tablet: 1mg, 2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Granisetron: (36 results)

Showing the first 20, Sorted by National Drug Code
  • 0054-0143 Granisetron 1 mg (Granisetron Hydrochloride 1.12 mg) Oral Tablet by Roxane Laboratories, Inc
  • 0093-7485 Granisetron 1 mg (Granisetron Hydrochloride 1.12 mg) Oral Tablet by Teva Pharmaceuticals USA Inc
  • 0143-9744 Granisetron Hydrochloride 1 mg/ml Intravenous Solution by West-ward Pharmaceutical Corp
  • 0143-9745 Granisetron Hydrochloride 4 mg/4ml Intravenous Solution by West-ward Pharmaceutical Corp
  • 16714-221 Granisetron 1 mg (Granisetron Hydrochloride 1.12 mg) Oral Tablet by Northstar Rx LLC
  • 17478-546 Granisetron Hydrochloride 1 mg/ml Intravenous Injection by Akorn Inc.
  • 17478-547 Granisetron Hydrochloride .1 mg/ml Intravenous Injection by Akorn Inc.
  • 25021-778 Granisetron Hydrochloride .1 mg/ml Intravenous Injection by Sagent Pharmaceuticals
  • 25021-779 Granisetron Hydrochloride 1 mg/ml Intravenous Injection by Sagent Pharmaceuticals
  • 25021-781 Granisetron Hydrochloride 1 mg/ml Intravenous Injection by Sagent Pharmaceuticals
  • 42043-390 Granisetron Hydrochloride 1 mg Oral Tablet, Film Coated by Orchidpharma Inc
  • 51079-472 Granisetron 1 mg (Granisetron Hydrochloride 1.12 mg) Oral Tablet by Udl Laboratories, Inc.
  • 51672-4138 Granisetron 1 mg (Granisetron Hydrochloride 1.12 mg) Oral Tablet by Taro Pharmaceuticals U.S.a., Inc.
  • 51991-735 Granisetron 1 mg (Granisetron Hydrochloride 1.12 mg) Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 52547-801 Granisol 2 mg/10ml Oral Solution by Pediatrx, Inc.
  • 55150-175 Granisetron Hydrochloride 1 mg/ml Intravenous Injection, Solution by Auromedics Pharma LLC
  • 55150-176 Granisetron Hydrochloride 4 mg/4ml Intravenous Injection, Solution by Auromedics Pharma LLC
  • 55390-250 Granisetron Hydrochloride .112 mg/ml Intravenous Injection, Solution by Bedford Laboratories
  • 55648-661 Granisetron Hydrochloride 1 mg/ml Intravenous Injection by Wockhardt Limited
  • 55648-662 Granisetron Hydrochloride .1 mg/ml Intravenous Injection by Wockhardt Limited
  • 16 more results ...

Other drugs which contain Granisetron or a similar ingredient: (3 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA